Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

FDA Grants Priority Review to Rusfertide for Polycythemia Vera

google.com·11w

New Drug Application Approved for Rusfertide for Adults with Polycythemia Vera

google.com·11w

IRON: Multiple late-stage clinical readouts and regulatory milestones expected in 2024 ...

google.com·11w

PharmaEssentia Announces Japan Approval of High-Dose Dosing Regimen for BESREMi

google.com·11w

FDA Grants Priority Review to Rusfertide in Polycythemia Vera

google.com·11w

FDA grants Takeda and Protagonist's rusfertide priority review

google.com·11w

A New Era in Blood Disorder Management: FDA Grants Priority Review to Rusfertide

google.com·11w

PharmaEssentia Announces Japan Approval of High-Dose Dosing Regimen for BESREMi

google.com·11w

Rusfertide Earns FDA Priority Review in Polycythemia Vera

google.com·11w

FDA Accepts New Drug Application for Rusfertide, Grants Priority Review In Polycythemia Vera

google.com·11w

PharmaEssentia Announces Japan Approval of High-Dose Dosing Regimen for BESREMi®

google.com·11w

Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New ...

google.com·11w

Takeda, Protagonist Say FDA Accepts New Drug Application for Potential Polycythemia ...

google.com·11w

Rusfertide still needs to be Verified | ApexOnco

google.com·11w

FDA Accepts NDA and Grants Priority Review for Rusfertide

google.com·11w

Takeda, Protagonist Win FDA Priority Review For Rusfertide In Polycythemia Vera

google.com·11w

China Approves Sino Biopharm's First-In-Class Oral Molecule For 1L Myelofibrosis

google.com·11w

Rusfertide Shows Significant Improvements in Patient Outcomes for Polycythemia Vera in ...

google.com·11w

Essential Thrombocythemia Can Prompt Nonarteritic Anterior Ischemic Optic Neuropathy

google.com·11w

Scientists Uncover New Treatment for Bone Marrow Cancer

google.com·11w

Log in to enable infinite scrolling